Heartware (HTWR) to Acquire Valtech Cardio
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/14/2026
- Nasdaq futures slide as AI warnings rattle markets; Nvidia, other chip stocks retreat
- Global AI stocks fall as industry chiefs call for slowing development
- Oil prices continue surge, rising 3% amid Saudi pipeline outage after attack
- BofA sees just 2% upside for the S&P 500 over the next 12 months
- Oracle raises full year profit guidance, stock rises after hours
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Goldman Sachs tech conference highlights AI spending outlook
- Dell shares surge on record AI server bookings
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- 'No panic anywhere' may be the problem, BofA strategists warn
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Canaccord Genuity Remains Bullish on Heartware (HTWR) Following Agreement to Acquire Valtech Cardio
September 2, 2015 9:32 AM EDTCanaccord Genuity maintained a Buy rating and $106.00 price target on Heartware Int'l (NASDAQ: HTWR) following the company's agreement to acquire privately held Valtech Cardio. Analyst Jason Mills said that this is the type of deal to which investors commonly overreact; but once the dust settles, he would be a buyer of this stock.
Mills commented, "HeartWares agreement to acquire... More
Heartware International's (HTWR) Valtech Cardio Acquisition Doesn't Make Sense, Says Northland
September 2, 2015 9:18 AM EDTNorthland Capital Markets maintained an Underperform rating on Heartware International (NASDAQ: HTWR) with a price target of $60. Analyst Suraj Kalia said the company's acquisition of Valtech Cardio does not makes sense.
Kalia explained, "Valtech is a pre-revenue company developing surgical & transcatheter mitral repair / replacement... More
Raymond James Downgrades Heartware (HTWR) to Market Perform
September 2, 2015 8:36 AM EDTRaymond James downgraded Heartware Int'l (NASDAQ: HTWR) from Outperform to Market Perform and removed its price target (prior $102.00).
For an analyst ratings summary and ratings history on Heartware Int'l click here. For more ratings news on Heartware Int'l click here.
Shares of Heartware Int'l closed at $81.81 yesterday.
... MoreBTIG Downgrades Heartware Int'l (HTWR) to Neutral
September 2, 2015 8:13 AM EDTBTIG downgraded Heartware Int'l (NASDAQ: HTWR) from Buy to Neutral. The change follows its acquisition of Valtech.
"While we understand the rationale of this acquisition and it may prove to be a strong asset over the next 3-5 years, we anticipate there... More
